AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
Daikin’s Open Innovation Lab invites startups of all stages and from all over the world to submit ideas and insights to collaborate and help develop solutions that can provide HVAC services and solutions fit for the remote/hybrid working world amid the current pandemic environment and thereafter.
Sourcemap: Supply chain transparency platform Leonardo Bonanni, Founder and CEO, Sourcemap
Tamr: Cloud-native data mastering solution for unprecedented scaling and reduced costs Mitch Tompkins, Sales Manager, Tamr
Sensai Analytics: Scaling Enterprise AI Ian Mathews. CEO & Co-founder, Sensai Analytics
ThruWave: 3D millimeter wave image sensors for verification and efficiency in industrial and commercial applications Matt Reynolds, Founder & CEO, ThruWave
Jeeva: Re-imagining Connectivity to Automate Consumable Replenishment Scott Bright,CEO, Jeeva
Wistron and Garage+ are accepting applications to their joint incubation program. The program is open to international startups that demonstrate a connection to the Taiwan market—whether through company registration, Taiwanese co-founders, or a local R&D office. Application Deadline: December 12, 2025.
The MIT Startup Exchange is looking for 3-4 MIT startups to present and exhibit at the MIT ILP one-day Taiwan symposium (Taipei, Taiwan; Wednesday July 17, 2019). Each selected startup will present a short lightning talk on a technology-based product they are bringing to market, including at least one compelling use case. All presenting startups are expected to exhibit as well.
John Andrews, CEO, Celect
Panel Discussion
Panelists:
Moderator: Trond Undheim, Ph.D., Lead, MIT Startup Exchange, MIT ILP
Lightning Talk and Exhibitor Opportunity, Organized by MIT Media Lab with contributions from MIT Startup Exchange and Takeda Pharmaceuticals